HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.
about
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couplesAntiretroviral therapy for prevention of HIV transmission in HIV-discordant couplesAntiretroviral therapy for prevention of HIV transmission in HIV-discordant couplesPrevention of HIV-1 infection with early antiretroviral therapyAntiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directionsA systematic review of evidence to inform HIV prevention interventions among men who have sex with men in EuropeHIV-1 prevention for HIV-1 serodiscordant couplesReview: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaAntiretroviral therapy for prevention of HIV transmission: implications for EuropeCost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling studyThe role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission modelsDevelopment of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria.The History of the HIV/AIDS Epidemic in Africa.Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement EffortsTreatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural UgandaTransmission selects for HIV-1 strains of intermediate virulence: a modelling approach.Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.Fertility desires among men and women living with HIV/AIDS in Nairobi slums: a mixed methods study.WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods.Reproductive assistance in HIV serodiscordant couples.HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South AfricaHIV treatment as prevention: optimising the impact of expanded HIV treatment programmesHIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru.Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.Changes in sexual behaviors among HIV-infected individuals after their HIV diagnosis in a rural prefecture of Eastern ChinaAdvances in HIV prevention for serodiscordant couples.Medical pluralism predicts non-ART use among parents in need of ART: a community survey in KwaZulu-Natal, South Africa.HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study.Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: systematic review and bayesian modeling.Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, ChinaLaboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumerationHealth outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in ZambiaHIV testing service awareness and service uptake among female heads of household in rural Mozambique: results from a province-wide survey.Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study
P2860
Q24197939-850344B4-886F-4139-B5B4-EC62EB73D94CQ24234597-66DCF819-4C2E-4497-AB45-2812F256094EQ24234903-6920ADB0-DB6E-4DD1-B16A-48A837175267Q24634688-0D792AEA-1CDB-4259-9445-E9577903A8DAQ26825761-175AB8A3-52AF-4709-A16B-E5272ACED896Q26825862-A162BDD9-F102-49AE-9E81-5411A5DBC3D4Q26866244-59DF0969-F0B3-4364-92B0-C7FD72D8B7DFQ26996011-A478F2A9-8386-499D-AE4E-1C8FF4A1B356Q27022927-81CD6A9E-9309-4819-8D7C-3A9DA0D751CEQ27023464-FA86C49C-859B-459B-BD1A-3C76863FAF12Q28488157-B108A1C2-E96C-439D-8AC6-5855003C80A7Q28658229-A4A320C9-F6EA-4D8E-9EC5-D1B929B70507Q30151894-EAA6C8E0-BD52-4E1B-B75A-0B0306613AD1Q30250286-6EBAFED0-861E-499D-8CC0-B8F43F8CC04EQ31128135-8FD9A6E6-3470-482E-B907-DA66A86FC0B2Q33685269-E64C8E8B-625C-4701-AF0A-76E06B844E43Q34055207-2AA26910-6D54-416D-B19E-88A5883D89C6Q34081339-8C106E5D-C2A7-4655-9D7F-7C436767A7DAQ34110536-730816E9-1E40-42EF-ADF4-B6817089607EQ34110875-C33248F4-9469-4C42-A8A7-335EBAFE174BQ34240563-F5E99740-EE76-41C1-BB8C-3DCEF57E6402Q34311329-2593365C-0E6E-46C7-922F-BF3FCBA9B039Q34339465-9DB0BF0E-AF9F-4833-ADDC-3ECA72E64A48Q34339517-627820C0-599D-422D-99FA-63DC1CEF4C9AQ34339523-4D54E90D-71F9-4EC3-887A-148EF9A9A044Q34458805-14E2714F-E264-4F0C-8CB9-5E5769FAFDE2Q34589562-AC00B5C5-CB8A-42DE-8354-2D2AC5CF06FBQ34635307-1042077B-61B1-41ED-B410-C948751F16C5Q34714168-3864FA26-D538-415A-80DD-1D41DD40F3A6Q34980396-EE891B56-BFC2-4B52-B774-FD2D1239332BQ35004616-3775A561-2088-4855-8148-CAB1321A108BQ35008374-34EF087C-3B0A-4AFC-AB99-5F3904D2A5BDQ35034154-D3B1CD1B-1ADE-4A91-9BD0-118D0C400AA4Q35043498-CAFF1E4E-806D-41FC-B384-EBCA15C1A2EDQ35092430-3A94C5A5-4192-4A20-9EF8-0E2F2EC67C69Q35113480-8E3F0069-0ACE-4D08-9826-34F471542E05Q35117125-8B969009-7AA9-4814-85BE-356AB4C8B681Q35124905-6B0A3EE5-63F3-4001-90B9-11B6012BC20FQ35146589-3CD5435D-4366-40B0-AD38-EE7275115CD4Q35327194-9A916EE7-8522-4227-BCED-D713F870194C
P2860
HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@ast
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@en
type
label
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@ast
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@en
prefLabel
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@ast
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@en
P2093
P2860
P50
P1433
P1476
HIV-1 transmission among HIV-1 ...... ion of antiretroviral therapy.
@en
P2093
Frederick Makumbi
Gertrude Nakigozi
Joseph Kagaayi
Maria Wawer
Steven J Reynolds
P2860
P304
P356
10.1097/QAD.0B013E3283437C2B
P407
P577
2011-02-01T00:00:00Z